Medifast is the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, which offers scientifically developed products, clinically proven plans and the support of Coaches and a Community to help Clients achieve Lifelong Transformation, One Healthy Habit at a Time®. Based on nearly 40 years of experience, Medifast has redefined direct selling by combining the best aspects of the model. Its community of thousands of independent OPTAVIA Coaches teach Clients how to develop holistic healthy habits through the proprietary Habits of Health® Transformational System. Medifast is ranked second on FORTUNE's 100 Fastest-Growing Companies list in 2020. The company was also named to Forbes' 100 Most Trustworthy Companies in America list in 2017.
Company profile
Ticker
MED
Exchange
Website
CEO
Daniel Chard
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
HEALTHRITE INC
SEC CIK
Corporate docs
Subsidiaries
Corporate Events, Inc. • Jason Enterprises, Inc. • Jason Pharmaceuticals, Inc. • Jason Properties, LLC • OPTAVIA, LLC • OPTAVIA Health Consultation (Shanghai) Co., Ltd. • OPTAVIA (Hong Kong) Limited • OPTAVIA (Singapore) PTE. LTD • Seven Crondall Associates, LLC ...
IRS number
133714405
MED stock data
Analyst ratings and price targets
Latest filings (excl ownership)
8-K
Medifast Enhances “Fuel for the Future” Program to Position the Business for Long-term Sustainable Growth
1 Jun 23
10-Q
2023 Q1
Quarterly report
1 May 23
8-K
Medifast Announces First Quarter 2023
1 May 23
DEF 14A
Definitive proxy
1 May 23
DEFA14A
Additional proxy soliciting materials
1 May 23
ARS
2022 FY
Annual report to shareholders
1 May 23
8-K
Departure of Directors or Certain Officers
20 Apr 23
8-K
Medifast Announces Quarterly Dividend
16 Mar 23
10-K
2022 FY
Annual report
21 Feb 23
8-K
Medifast Announces Fourth Quarter and Full Year 2022
21 Feb 23
Transcripts
MED
Earnings call transcript
2023 Q1
1 May 23
MED
Earnings call transcript
2022 Q4
21 Feb 23
MED
Earnings call transcript
2022 Q3
4 Nov 22
MED
Earnings call transcript
2022 Q2
4 Aug 22
MED
Earnings call transcript
2022 Q1
3 May 22
MED
Earnings call transcript
2021 Q4
24 Feb 22
MED
Earnings call transcript
2021 Q3
5 Nov 21
MED
Earnings call transcript
2021 Q2
5 Aug 21
MED
Earnings call transcript
2021 Q1
4 May 21
MED
Earnings call transcript
2020 Q4
26 Feb 21
Latest ownership filings
Financial summary
| Quarter (USD) | Mar 23 | Dec 22 | Sep 22 | Jun 22 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
Institutional ownership, Q1 2023
88.4% owned by funds/institutions
| 13F holders | Current |
|---|---|
| Total holders | 256 |
| Opened positions | 39 |
| Closed positions | 51 |
| Increased positions | 105 |
| Reduced positions | 77 |
| 13F shares | Current |
|---|---|
| Total value | 990.15 bn |
| Total shares | 9.63 mm |
| Total puts | 151.70 k |
| Total calls | 76.80 k |
| Total put/call ratio | 2.0 |
| Largest owners | Shares | Value |
|---|---|---|
| BLK Blackrock | 1.79 mm | $185.75 bn |
| Vanguard | 1.72 mm | $178.56 bn |
| Renaissance Technologies | 651.01 k | $68.34 bn |
| STT State Street | 379.96 k | $40.01 bn |
| MS Morgan Stanley | 362.33 k | $37.56 bn |
| Dimensional Fund Advisors | 332.74 k | $34.49 bn |
| PFG Principal Financial Group Inc - Registered Shares | 223.19 k | $23.14 bn |
| Geode Capital Management | 221.07 k | $22.92 bn |
| BK Bank Of New York Mellon | 185.74 k | $19.26 bn |
| JPM JPMorgan Chase & Co. | 166.67 k | $17.28 bn |
Recent insider trades
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 9 May 23 | Xian Ming | RSU Common Stock | Buy | Acquire P | No | No | 87.5 | 12.379 | 1.08 k | 1,985.834 |
| 9 May 23 | Hallquist Constance J. | Common Stock | Buy | Acquire P | No | No | 87.5 | 13.342 | 1.17 k | 7,590.853 |
| 9 May 23 | Thomas Andrea B | Common Stock | Buy | Acquire P | No | No | 87.5 | 12.949 | 1.13 k | 3,046.621 |
| 9 May 23 | Schlackman Scott | Common Stock | Buy | Acquire P | No | No | 87.5 | 13.145 | 1.15 k | 7,293.237 |
| 9 May 23 | Hoer Michael A. | Common Stock | Buy | Acquire P | No | No | 87.5 | 12.772 | 1.12 k | 5,170.065 |
News
Wall Street's Most Accurate Analysts Say Hold These 3 Defensive Stocks With Over 6% Dividend Yields
5 Jun 23
Stocks That Hit 52-Week Lows On Thursday
1 Jun 23
Stocks That Hit 52-Week Lows On Wednesday
31 May 23
Stocks That Hit 52-Week Lows On Tuesday
30 May 23
Check Out 3 High-Yielding Dividend Stocks In Consumer Staples Sector From Wall Street's Most Accurate Analysts
4 May 23
Press releases
Nightfood Is In A Sweet Spot Of Opportunity, Targets $50 Billion+ Nighttime Snack Market Opportunity ($NGTF)
7 Jun 23
Medifast Enhances "Fuel for the Future" Program to Position the Business for Long-term Sustainable Growth
1 Jun 23
Nightfood Is A Category Of One, Targeting the $50 Billion+ Nighttime Snack Market Opportunity ($NGTF)
30 May 23
Medifast Announces First Quarter 2023 Financial Results
1 May 23
Medifast to Announce Financial Results for the First Quarter Ended March 31, 2023
17 Apr 23